SERA PROGNOSTICS INC-A Share Price Today: Live Updates & Key Insights

SERA PROGNOSTICS INC-A share price today is $1.835, up 2.51%. The stock opened at $1.8329 against the previous close of $1.79, with an intraday high of $1.99 and low of $1.65.

SERA PROGNOSTICS INC-A Share Price Chart

SERA PROGNOSTICS INC-A

us-stock
To Invest in {{usstockname}}
us-stock

SERA PROGNOSTICS INC-A Share Price Performance

$1.835 0.0251(2.51%) SERA at 23 Mar 2026 03:11 PM Medical Devices
Lowest Today 1.65
Highest Today 1.99
Today’s Open 1.8329
Prev. Close 1.79
52 Week High 4.20
52 Week Low 1.37
Day’s Range: Low 1.65 High 1.99
52-Week Range: Low 1.37 High 4.20
1 day return -
1 Week return -9.66
1 month return -22.08
3 month return -47.76
6 month return -39.08
1 year return -54.77
3 year return -54.83
5 year return -84.33
10 year return -

SERA PROGNOSTICS INC-A Institutional Holdings

Baker Bros Advisors LP 14.25

Whetstone Capital Advisors, LLC 8.96

Aberdeen Group PLC 5.91

Vivo Capital, LLC 4.28

Vanguard Group Inc 3.21

abrdn Healthcare Investors 3.06

abrdn Healthcare Opportunities 2.94

Vanguard Total Stock Mkt Idx Inv 2.30

Citadel Advisors Llc 1.83

CapTrust Financial Advisors 1.39

Geode Capital Management, LLC 0.87

Vanguard Institutional Extnd Mkt Idx Tr 0.79

SMH Capital Inc. 0.68

Awm Investment Company Inc 0.54

BlackRock Inc 0.46

Fidelity Extended Market Index 0.42

State Street Corp 0.32

Millennium Management LLC 0.29

Blackrock Extended Mkt Fund CF 0.29

GSA Capital Partners LLP 0.28

CI Private Wealth LLC 0.26

Extended Equity Market Fund K 0.25

Northern Trust Corp 0.23

Morgan Stanley - Brokerage Accounts 0.22

iShares Micro-Cap ETF 0.21

Bank of New York Mellon Corp 0.20

Perigon Wealth Management, LLC 0.19

Susquehanna International Group, LLP 0.19

Fidelity Total Market Index 0.13

Bridgeway Ultra-Small Company Market 0.11

Fidelity Series Total Market Index 0.10

Spartan Extended Market Index Pool F 0.10

NT Ext Equity Mkt Idx Fd - L 0.09

Northern Trust Extended Eq Market Idx 0.07

NT Ext Equity Mkt Idx Fd - NL 0.06

Goldman Sachs Absolute Ret Trckr Instl 0.06

Spartan Total Market Index Pool G 0.06

Fidelity Nasdaq Composite Index 0.06

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.05

Vanguard Instl Ttl Stck Mkt Idx Tr 0.05

SERA PROGNOSTICS INC-A Market Status

Strong Buy: 2

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

SERA PROGNOSTICS INC-A Fundamentals

Market Cap 70.82 M

PB Ratio 0.8594

PE Ratio 0.0

Enterprise Value 29.77 M

Total Assets 101.93 M

Volume 164170

SERA PROGNOSTICS INC-A Company Financials

Annual Revenue FY23:330000 0.3M, FY22:268000 0.3M, FY21:82000 0.1M, FY20:25000 0.0M, FY19:36000 0.0M

Annual Profit FY23:85000 0.1M, FY22:75000 0.1M, FY21:45000 0.0M, FY20:14000 0.0M, FY19:18000 0.0M

Annual Net worth FY23:-38063000 -38.1M, FY22:-44247000 -44.2M, FY21:-36228000 -36.2M, FY20:-21607000 -21.6M, FY19:-20439000 -20.4M

Quarterly Revenue Q3/2025:16000 0.0M, Q2/2025:17000 0.0M, Q1/2025:38000 0.0M, Q3/2024:29000 0.0M, Q2/2024:24000 0.0M

Quarterly Profit Q3/2025:-25000 -0.0M, Q2/2025:-24000 -0.0M, Q1/2025:-2000 -0.0M, Q3/2024:16000 0.0M, Q2/2024:-344000 -0.3M

Quarterly Net worth Q3/2025:-7814000 -7.8M, Q2/2025:-8046000 -8.0M, Q1/2025:-8187000 -8.2M, Q3/2024:-7919000 -7.9M, Q2/2024:-8303000 -8.3M

About SERA PROGNOSTICS INC-A & investment objective

Company Information Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Organisation Medical Devices

Employees 63

Industry Medical Devices

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

SERA PROGNOSTICS INC-A FAQs

What is the share price of SERA PROGNOSTICS INC-A today?

The current share price of SERA PROGNOSTICS INC-A is $1.835.

Can I buy SERA PROGNOSTICS INC-A shares in India?

Yes, Indian investors can buy SERA PROGNOSTICS INC-A shares by opening an international trading and demat account with Motilal Oswal.

How to buy SERA PROGNOSTICS INC-A shares in India?

You can easily invest in SERA PROGNOSTICS INC-A shares from India by:

Can I buy fractional shares of SERA PROGNOSTICS INC-A?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of SERA PROGNOSTICS INC-A?

SERA PROGNOSTICS INC-A has a market cap of $70.82 M.

In which sector does SERA PROGNOSTICS INC-A belong?

SERA PROGNOSTICS INC-A operates in the Medical Devices sector.

What documents are required to invest in SERA PROGNOSTICS INC-A stocks?

To invest, you typically need:

What is the PE and PB ratio of SERA PROGNOSTICS INC-A?

The PE ratio of SERA PROGNOSTICS INC-A is N/A and the PB ratio is 0.86.